Description
BLOOD AND BLOOD PRODUCTS
First action · last action
2023-10-01 · 2026-06-01
Transactions
8
First transaction's obligation
$1,284,175
Base + all options value (sum of deltas)
$6,396,421
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
621991 · BLOOD AND ORGAN BANKS
Modification chain · 8 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2023-10-01+$1,284,175= $1,284,175
- Mod P000012024-02-20-$201,550= $1,082,625
- Mod P000022024-10-01+$1,312,403= $2,395,028
- Mod P000032024-11-15+$56,962= $2,451,990
- Mod P000042025-10-01+$1,344,776= $3,796,766
- Mod P000052026-04-03-$215,450= $3,581,316
- Mod P000062026-04-21+$17,397= $3,598,713
- Mod P000072026-06-01+$0= $3,598,713
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2023-10-01 | +$1,284,175 | $1,284,175 | BLOOD AND BLOOD PRODUCTS |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-02-20 | −$201,550 | $1,082,625 | BLOOD AND BLOOD PRODUCTS |
| Mod P00002· EXERCISE AN OPTION | 2024-10-01 | +$1,312,403 | $2,395,028 | BLOOD AND BLOOD PRODUCTS |
| Mod P00003· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-11-15 | +$56,962 | $2,451,990 | BLOOD AND BLOOD PRODUCTS |
| Mod P00004· EXERCISE AN OPTION | 2025-10-01 | +$1,344,776 | $3,796,766 | BLOOD AND BLOOD PRODUCTS |
| Mod P00005· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2026-04-03 | −$215,450 | $3,581,316 | BLOOD AND BLOOD PRODUCTS |
| Mod P00006· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2026-04-21 | +$17,397 | $3,598,713 | BLOOD AND BLOOD PRODUCTS |
| Mod P00007· OTHER ADMINISTRATIVE ACTION | 2026-06-01 | +$0 | $3,598,713 | BLOOD AND BLOOD PRODUCTS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI JXA3FSKNMXZ3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24725C0072 | 247-NETWORK CONTRACT OFFICE 7 (36C247) · Q515 · MEDICAL- PATHOLOGY | $343,759 | FY2025 |
| 36C24720C0197 | 247-NETWORK CONTRACT OFFICE 7 (36C247) · Q515 · MEDICAL- PATHOLOGY | $700,996 | FY2020 |
| 36C24720C0036 | 247-NETWORK CONTRACT OFFICE 7 (36C247) · Q301 · REFERENCE LABORATORY TESTING | $219,377 | FY2020 |
| 36C24719N0673 | 247-NETWORK CONTRACT OFFICE 7 (36C247) · Q999 · MEDICAL- OTHER | $236,768 | FY2019 |
| 36C24819C0004 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $4,573,367 | FY2019 |
| 36C24718N1053 | 247-NETWORK CONTRACT OFFICE 7 (36C247) · Q999 · MEDICAL- OTHER | $309,431 | FY2018 |
Other recipients under 6505 from 248-NETWORK CONTRACT OFFICE 8 (36C248) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24826F0207 | CSL BEHRING L.L.C. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $183,903 | FY2026 |
| 36C24826P1108 | ASD SPECIALTY HEALTHCARE, LLC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $54,600 | FY2026 |
| 36C24826P1090 | SIRTEX MEDICAL INC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $45,825 | FY2026 |
| 36C24826N0511 | BIOMERIEUX INC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $61,788 | FY2026 |
| 36C24826N0693 | MEDI-PHYSICS, INC. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $111,150 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24824P0016_3600_-NONE-_-NONE- · retrieved 2026-09-26.